Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Lixte Biotech Hlds (LIXT)

Lixte Biotech Hlds (LIXT)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Lixte Biotechnology's LB-100 Shown in Animal Models to Significantly Reduce Behavioral Sensitization, an Important Feature of Methamphetamine Addiction

A series of recent pre-clinical reports demonstrates LB-100's effectiveness in various

LIXT : 2.00 (-6.54%)
LIXTE BIOTECHNOLOGY'S LB-100 ELICITS ANTI- TUMOR ACTIVITY IN SMALL LUNG CANCER MODELS BY UNIQUE MECHANISMS IN AN IMPORTANT PRE-CLINICAL STUDY

A Pre-Clinical Study Reports that LB-100 Potentiates Standard Therapy for Small Cell Lung Cancer Providing a Strong Rationale for a Clinical Trial of LB-100 in Small Cell Lung Cancer Recently Initiated...

LIXT : 2.00 (-6.54%)
LIXTE BIOTECHNOLOGY COMMENTS ON REPORT THAT ITS PP2A INHIBITOR LB-100 COMBINED WITH ANOTHER INVESTIGATIONAL AGENT STIMULATES BONE GROWTH IN MODELS OF DWARFISM

LixteBiotechnology Holdings, Inc. (Nasdaq:LIXTE) a clinical-stage drug discovery company developing pharmacologically active drugs for improving cancer treatments, commented on pre-clinical research demonstrating...

LIXT : 2.00 (-6.54%)
Lixte Biotechnology Comments on Outside Research Citing LB-100's PP2A Inhibition as a Potential Therapeutic Strategy for Triple-Negative Breast Cancer

Lixte Biotechnology Holdings, Inc. (Nasdaq: LIXT) ("Lixte" or the "Company") noted that Julio Pimentel, a fourth-year doctoral student in the Wayne State University School of Medicine's Cancer Biology...

LIXT : 2.00 (-6.54%)
Lixte Biotechnology to Present its Drug Development Pipeline for Cancer Treatment at The MoneyShow Virtual Expo on July 14, 2021

Presentation to highlight Company's current clinical study of lead compound LB-100 for Small Cell Lung Cancer

LIXT : 2.00 (-6.54%)
Lixte Biotechnology and City of Hope Enroll First Patient in Phase 1b Trial of Lead Compound LB-100 for Treatment of Small Cell Lung Cancer

-- Due to the aggressive progression of small cell lung cancer, it is possible that therapeutic benefit in patients may be seen in this early-stage clinical trial

LIXT : 2.00 (-6.54%)
Sidoti Microcap Virtual Conference

SCAN.VN : 0.460 (-1.08%)
MDP.VN : 7.750 (-4.91%)
SOLR.VN : 0.205 (unch)
MEDXF : 2.4800 (+2.90%)
GLVMF : 9.8557 (+7.83%)
NTSFF : 0.9521 (+0.21%)
UGEIF : 1.1100 (+1.80%)
LDDFF : 0.3700 (+1.98%)
LXR.TO : 0.1000 (unch)
PANL : 4.64 (-4.33%)
POETF : 0.7974 (+0.78%)
TNYYF : 0.8472 (+3.47%)
URG : 1.7400 (+2.96%)
DBD : 9.43 (-4.84%)
GENTF : 48.8400 (-2.82%)
BDI.TO : 3.35 (unch)
SLNG : 6.40 (+3.39%)
STRR : 2.53 (+0.80%)
VNRX : 3.08 (unch)
ALOT : 15.92 (-0.38%)
JRSH : 7.70 (-0.65%)
DHX : 4.26 (+1.91%)
TREC : 8.06 (+0.75%)
MINM : 1.7600 (-3.30%)
ARHH : 1.5300 (-4.38%)
GAIA : 9.50 (-0.52%)
GSIT : 5.56 (-0.71%)
HIL : 2.25 (+0.90%)
MKGI : 2.27 (+7.08%)
OSS : 5.06 (-0.20%)
VERB : 1.8600 (+5.08%)
ABML : 1.3500 (+3.85%)
CVEO : 22.03 (+2.37%)
ISUN : 8.53 (-0.70%)
LIXT : 2.00 (-6.54%)
TESS : 5.44 (+2.64%)
WSTG : 27.19 (-1.16%)
APEN : 9.08 (-0.87%)
CTG : 8.31 (+0.24%)
EML : 24.30 (+1.93%)
ACU : 36.20 (+0.17%)
AMST : 1.7300 (+1.76%)
BSET : 18.06 (-0.61%)
BKEPP : 8.24 (-0.48%)
BKEP : 3.07 (-0.97%)
EFOI : 3.09 (-1.28%)
FLXS : 33.01 (-2.68%)
MDCA : 5.42 (-3.39%)
OBLG : 2.26 (+1.80%)
PCTI : 6.28 (unch)
SAMG : 15.44 (-0.39%)
VQS.TO : 4.02 (-2.66%)
CVGI : 9.11 (-1.19%)
ORN : 5.01 (-0.79%)
WLMS : 4.34 (-2.69%)
LXU : 9.64 (+6.28%)
LCUT : 17.31 (+0.23%)
LINC : 6.08 (-1.78%)
STRT : 36.15 (-0.99%)
GVP : 1.3400 (+3.88%)
LMB : 6.25 (-4.43%)
AFI : 3.11 (-2.81%)
LIXTE BIOTECHNOLOGY HOLDINGS, INC. ANNOUNCES THE APPOINTMENT OF REGINA BROWN TO ITS BOARD OF DIRECTORS

Lixte Biotechnology Holdings, Inc. (Nasdaq:LIXT) today announced the appointment of Regina Brown, CPA to its board of directors. She will serve as an independent director and audit committee chair.

LIXT : 2.00 (-6.54%)
Lixte Biotechnology to Present Key Advantages of Novel Cancer Drug Candidate LB-100 at the Sidoti Virtual Microcap Conference on May 20

Multiple pre-clinical studies indicate that Lixte's lead clinical drug candidate LB-100 enhances the effectiveness of many standard anticancer treatments

LIXT : 2.00 (-6.54%)
Lixte Biotechnology to Discuss Pipeline of Clinical Investigations for Four Cancer Targets at the Benzinga Global Small Cap Conference Being Held May 13-14

-- Lixte's pipeline includes three clinical studies and one pharmacology study of lead drug candidate LB-100

LIXT : 2.00 (-6.54%)

Barchart Exclusives

Cryptocurrencies Sink in Reaction to Evergrande Group’s Debt Crisis
Bitcoin (^BTCUSD ) is down more than -2% today at a 1-1/2 month low, adding to Monday’s -8% plunge. Also, Ethereum (^ETHUSD ) is down more than -1% today on top of Monday’s -10% plunge to a 6-week low. Cryptocurrencies have tumbled this week as they succumbed to Monday’s sell-off... Read more

Barchart Futures Commentary

Barchart Futures is a twice weekly newsletter that features a selection of the latest and best commodities commentary appearing on Barchart.com. Delivered every Wednesday and Friday morning to your inbox.

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar